BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10900162)

  • 1. Noncognate binding to histones of IgG from patients with idiopathic systemic lupus erythematosus.
    Gussin HA; Tselentis HN; Teodorescu M
    Clin Immunol; 2000 Aug; 96(2):150-61. PubMed ID: 10900162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
    Teodorescu M; Ustiyan V; Russo K; Rubin RL
    Clin Immunol; 2004 Feb; 110(2):145-53. PubMed ID: 15003811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihistone antibodies in systemic lupus erythematosus.
    Rubin RL; Waga S
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():118-26. PubMed ID: 2441043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.
    Grootscholten C; van Bruggen MC; van der Pijl JW; de Jong EM; Ligtenberg G; Derksen RH; Berden JH;
    Arthritis Rheum; 2003 May; 48(5):1355-62. PubMed ID: 12746908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone.
    Rumore PM; Steinman CR
    J Clin Invest; 1990 Jul; 86(1):69-74. PubMed ID: 2365827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: glycated-histones as likely trigger for SLE?
    Alam S; Arif Z; Alam K
    Autoimmunity; 2015 Feb; 48(1):19-28. PubMed ID: 25065453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a flow cytometry microsphere assay to detect anti-histone antibody in dogs.
    Paul S; Wilkerson MJ; Shuman W; Harkin KR
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):315-25. PubMed ID: 16005522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
    Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus.
    Mannik M; Merrill CE; Stamps LD; Wener MH
    J Rheumatol; 2003 Jul; 30(7):1495-504. PubMed ID: 12858447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.